3 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
Follow CCX282-B: new trials by email Literature Review of CCX282-B trials Research Report on CCX282-B
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study of CCX282-B in Patients With Celiac Disease CCX282-B, Placebo - Celiac Disease | Phase 2 | Completed | Amgen | 90 | 2007-10-01 | 2025-03-06 |
| A Study to Evaluate the Efficacy and Safety of CCX282-B in Subjects With Moderate to Severe Crohn's Disease CCX282-B - Crohn's Disease | Phase 2 | Completed | Amgen | 436 | 2006-03-01 | 2025-03-06 |
| Safety and Activity Study of an Oral Medication to Treat Moderate to Severe Crohn's Disease CCX282-B - Crohn Disease | Phase 2 | Completed | Amgen | 70 | 2004-08-01 | 2025-03-06 |
Crohn Disease (2) · Celiac Disease (1)
Amgen (3)
Australia (1) · Austria (1) · Belgium (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · Israel (1) · Netherlands (1) · Poland (1)